Emerging Innovations in Cardiology

With cardiovascular disease (CVD) remaining the #1 cause of death in the United States and globally, innovations that help Cardiologists detect, diagnose and treat CVD are vital.

In fact, the American Heart Association estimates that improving cardiovascular health in U.S. adults could reduce cardiovascular events by 2 million annually.

Beyond educating patients about preventative lifestyle changes, Cardiologists have a unique opportunity to advance patient outcomes and reduce CVD-related mortality by adopting innovative approaches to care.

As recruiters working with Cardiology clinicians and specialists every day, Provider Solutions & Development (PS&D) strives to be a trusted advisor to clinicians exploring opportunities where innovation, research and advancements in care are at the forefront. Staying current on the latest in Cardiology helps us connect Cardiologists with roles that align with their professional goals and clinical interests.

Cardiology advancements are moving at a remarkable pace in several key areas, and clinicians actively seeking innovative ways to care for patients can have a big impact on the field and the wider population. No matter where you are in your Cardiology career, there are several innovations you should know about.

Diagnostic Innovations Helping Detect CVD Earlier, Faster and More Accurately

One of the areas with the most potential is diagnosing CVD quickly and accurately, as early detection is critical to reducing catastrophic medical events, like heart attacks.

From advancements in screening technology and methods to data analytics tools, Cardiologists and researchers are innovating to not only help improve detection and diagnosis of heart disease for patients, but to help reduce burnout among clinicians and expand access to care.

Lp(a) Research & Screening

Cardiologists are already familiar with low-density lipoprotein (LDL) cholesterol as the primary test subject of screening for heart disease risk, but new studies are finding that lipoprotein(a)[Lp(a)] might be equally important to screening accuracy.

Lp(a) is almost entirely genetically inherited and can sometimes be elevated in individuals who have otherwise tested in normal ranges for LDL cholesterol. It also carries another protein that creates an even higher heart attack risk than LDL. Though tests are already available to Cardiology specialists, they are not often ordered because there has not been an approved way to manage elevated Lp(a) levels. Even diet and exercise have little impact on reducing Lp(a).

With 20% of the global population affected by elevated Lp(a), research into this often-overlooked cardiovascular risk factor is essential. Greater understanding of Lp(a) may encourage more Cardiologists to order testing and could bring several experimental drugs to trail that may provide a treatment path.

Artificial Intelligence (AI) in Cardiology

AI has already made an impact in diagnosing heart disease, mainly through tools used to analyze data from electrocardiograms (ECGs) and diagnose heart conditions like acute coronary syndrome (ACS), cardiac arrhythmias and cardiomyopathy. AI’s data-analyzing capabilities create unique opportunities to make diagnosis quicker, which improves patient outcomes and expands access to care.

Other areas where Cardiologists might see AI become more embedded into workflows and everyday care include:

• Autonomous Care: The U.S. government is currently funding the development of autonomous care in a clinical setting, starting with heart failure and the Advanced Research Projects Agency for Health’s (ARPA-H) Agentic AI-EnableD CardioVascular CAre TransfOrmation (ADVOCATE) program. This technology could help bridge the gap in care caused by the physician shortage and allow experienced clinicians to see more patients.

• Reducing Administrative Burden: On the non-patient-facing side, AI in the form of computer-assisted physician documentation (CAPD) can alleviate administrative burden that contributes to burnout among clinicians and allow for more face-to-face care.

• Identifying Risks, Gaps in Care and Intervention Effectiveness: Research by the Providence Heart Institute’s Center for Cardiovascular Analytics, Research + Data Science (CARDS), is using AI to analyze large, real-world datasets to identify patients at higher risk for heart attacks, discover areas to improve care and evaluate the effectiveness of certain interventions.

Prevention is the New Cure

As Cardiologists are already intimately familiar, eating a balanced, healthy diet and at least 150 minutes of physical activity weekly are two of the most important ways adults can improve their heart health. When coupled with regular cholesterol testing and medication or other management for CVD risk factors, we are already moving toward reducing CVD among the global population.

In addition to education and action around heart health, the general public appears to be shifting to a more proactive approach to healthcare, which may make prevention efforts more effective. In 2025, the U.S. consumer healthcare market grew to $107 billion, reflecting a continued focus on wellness, prevention and self-directed care.

Two areas where innovation in heart disease prevention is particularly impactful for Cardiologists are in wearables and gene editing.

Wearables for At-Home Monitoring & Proactive Health

In Rock Health’s 2025 Consumer Adoption of Digital Health Survey, nearly 50% of respondents reported owning a wearable, which includes watches, rings, connected blood pressure cuffs and more. These technologies are helping individuals track their health more closely while giving clinicians more real-world data to detect and diagnose CVD.

For example, in a 2025 study, it was determined that the Apple Watch is highly accurate in detecting atrial fibrillation (AFib) and is a convenient way for patients to measure cardiovascular abnormalities and see specialists sooner than they would otherwise.

On the clinician side, Cardiologists have already expressed interest in the data wearables collect and in finding ways to create a system-like approach to capture and leverage the data in patient care. There is certainly work to be done in this area, both in terms of data collection and accuracy and in how that data is provided to and used by clinicians, but digital wellness is continuing to grow and will likely play an important role in diagnostics in the near future.

CRISPR Gene Editing for Cholesterol

CRISPR-Cas9 won the Nobel Prize in Chemistry in 2020, and since its completion in 2012, it has been a major area of innovation among clinicians and researchers. Some of the most prominent applications in medicine include cancer cell correction, rapid detection of viral infections and stem cell therapy, with dozens of other uses already discovered or in early research phases.

For Cardiology, one of the most impactful CRISPR-Cas9 applications is in cholesterol reduction. In Phase 1 of a clinical trial published in late 2025, a gene-editing therapy called CX310 reduced LDL cholesterol by 50% and triglycerides by 55% after a single infusion. According to the researchers running the trial, this was an unprecedented result, and success in subsequent trials could see CX310 leading to a dramatic reduction in cardiovascular risk among adults with lipid disorders.

Therapies Providing New, Better Options to Treat Heart Disorders & Manage Risk

Despite the continued advancements in prevention, detection and diagnosis of heart disease and other cardiovascular disorders, half of all adults in the U.S. still have some form of CVD, with high blood pressure, diabetes and obesity being the primary drivers.

Many therapies and medications are being developed and studied to make treatment of heart disorders better, faster and more accessible. Two areas with the potential to be particularly impactful in Cardiology are GLP-1s and Lp(a)-targeted RNA therapies.

A 2025 study from Mass General Brigham found that GLP-1 drugs tirzepatide and semaglutide both reduce the risk of heart attack, stroke and death from any cause. While these drugs are still fairly new, this early research suggests that using a GLP-1 as a way to manage type 2 diabetes — one of the key drivers of CVD — saw a 13-18% reduced risk of stroke and heart attack, depending on the specific medication being used.

As previously mentioned, Lp(a) has been known to carry a higher risk of heart attack, but it is frequently left untested because of a lack of treatment options when elevated levels are discovered. Several active clinical studies are aiming to change that.

One trial, currently in phase 3, is testing the effectiveness of the drug pelacarsen to stop the liver from producing the extra protein carried by Lp(a) that leads to higher heart attack risk. Early trials showed weekly injections could reduce Lp(a) levels by up to 80%.

As more drugs pass clinical trials and prove effectiveness, managing a previously untreatable risk factor for CVD will be much easier and can help Cardiologists fill a significant gap in cardiovascular care.

Moving Cardiology Forward in Your Next Career Search

There is so much innovation in Cardiology right now, and while the medical field continues to face a shortage of Cardiologists, clinicians are at the forefront of not only identifying and launching new technologies and care methods, but also of applying those advancements to improve patient outcomes and access to care.

In our experience, opportunities to innovate are often the biggest requirements for Cardiology clinicians during their job search, and many organizations, like members of the Providence Heart Institute and others, are seeking clinicians who are passionate about advancing the field.

If you’re a clinician looking for more innovation opportunities in your next role, it’s important to be intentional early in the job search. Vetting organizations before applying to open roles and knowing what questions to ask during interviews are two of the best ways Cardiologists can ensure the right fit, and PS&D is your guide through the entire process.

Our specialty is helping clinicians find and land roles at organizations that share their values while meeting other role requirements that matter to them, from location and schedule to compensation and team structure. You can browse open Cardiology roles through our partner organizations here or reach out for personalized job search support.